Journal of Vaccines & Vaccination

Department of Endocrinology, Peerless Hospitals, Kolkata, India

Biography

Dr. Kalyan Kumar Gangopadhyay (MD,FRCP,CCST) is a renowned Endocrinologist & Diabetologist and has practiced extensively in India and abroad which included work as a Consultant in Diabetes in University Hospital, Birmingham, UK. Currently, he is a senior Endocrinologist in the CK Birla Group of Hospitals, Kolkata. Dr. Gangopadhyay has won many awards and accolades in UK including the Stephen Whitaker prize for the best paper – West Midlands, UK, Owen Wade prize in Birmingham, First prize for the best presentation in Society for Endocrinology, London, Nussey Prize in University Hospital Birmingham amongst others. 

Publications

• Short Communication   
  No Role of HCQ in COVID-19 Prophylaxis: A Survey amongst Indian Doctors
  Author(s): Debasis Datta, Samit Ghosal*, Binayak Sinha, Sujata Datta, Twisha Chakraborty, Kalyan Kumar Gangopadhyay and Arup Ratan Dutta
  
  The COVID-19 pandemic is being tackled on two fronts-prevention and treatment. In addition to behavioural strategies and vaccines (eagerly awaited), pharmacotherapy is also being employed in certain regions as a preventive strategy. In India, hydroxychloroquine (HCQ), ivermectin, a variety of vitamin supplements are being used, with HCQ being the most popular among healthcare professionals. In addition to the evidence-based recommendations, it is important to ascertain the situation on the ground. We conducted a multicentric survey among physicians from a wide range of specialities to ascertain the usage on HCQ and its effects of COVID-19 prevention. We did not find any significant impact of HCQ on the prevention of COVID-19 (p=0.54) independent of the duration of its usage. This pilot project has the potential to act as a backbone for a larger study exploring th.. View more»
  

  DOI: 10.35248/2157-7560.20.S6.002

  Abstract HTML PDF